MARK QUIM: Open Payments
NPI 1780456350 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 7 payments from 3 companies in 2025. Trend: 2023 $248 · 2024 $201 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $206 |
| Janssen Pharmaceuticals, Inc | 2 | $115 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
Products named: ABILIFY MAINTENA, UZEDY, INVEGA SUSTENNA, REXULTI, SPRAVATO.
Industry payments across NV — which companies pay providers there.
